Burns > 15 % total burned surface area T29.0
Conditions
Interventions
Group 1: From routine morning blood draws on days 0–20, 50 µl are taken each time and analyzed using abioSCOPE. The quantitative result of the analysis (PSP) is usually displayed on the device's scree
that is, the test result is not visible but is stored on a patient-specific basis and only retrieved for evaluation after the test is completed. The PSP values ??are therefore not visible to the clini
only age and gender are documented for the analysis. This largely prevents the subsequent identification of patients. In accordance with legal requirements, the documentation forms are stored in the h
Sponsors
Klinikum St. Georg gGmbH
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients = 18 years Burns > 15% of total body surface area, 2nd-3rd degree
Exclusion criteria
Exclusion criteria: Lack of consent to study participation Hospital admission > 24 hours after burn injury Primarily palliative therapy Known acute or chronic pancreatitis or pancreatic cancer
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Correlation between PSP and the clinical diagnosis of bacteremia and/or sepsis within the first 21 days after burn injury. PSP is determined bedside using AbioSCOPE on EDTA blood. | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity, specificity, and positive and negative predictive value of PSP compared to CRP, PCT, and IL6 | — |
Countries
Germany
Contacts
Public ContactJochen Gille
Klinikum St. Georg gGmbH
Outcome results
None listed